Education, Science, Technology, Innovation and Life
Open Access
Sign In

Construction of Management Index System for Rational Drug Use of Key Monitoring Drugs

Download as PDF

DOI: 10.23977/socsam.2025.060116 | Downloads: 1 | Views: 255

Author(s)

Yangke He 1

Affiliation(s)

1 Lee's Pharmaceutical Holdings Limited, Chengdu, Sichuan, 610066, China

Corresponding Author

Yangke He

ABSTRACT

The purpose of this study is to build a scientific, systematic and operable management index system for rational drug use of key monitoring drugs, so as to standardize clinical drug use behavior, improve medical quality and reduce medical costs. The research adopts a three-stage path of theoretical construction-empirical verification-dynamic optimization. Through literature research, policy analysis, hospital practice investigation, Delphi method and analytic hierarchy process (AHP), a three-stage index system covering drug procurement, prescription review, clinical use and adverse reaction monitoring is constructed. The system includes 4 first-level indicators, 8 second-level indicators and 17 third-level indicators. The weight distribution is scientific and reasonable, and 82% of them are quantitative indicators that can be measured by data. In the empirical verification stage, six different levels of medical institutions were selected for pilot operation. The results of double difference analysis showed that the experimental group was significantly better than the control group in the core evaluation indicators such as average prescription amount, antibacterial drug utilization rate and prescription intervention response time. In addition, the study also established a dynamic optimization mechanism based on PDCA cycle and a "four-in-one" information platform to ensure the continuous adaptability and scientificity of the index system. The index system constructed in this study has the characteristics of policy compliance, clinical practicability, dynamic adaptability and data integration, which fully meets the requirements of DRG payment reform, provides a scientific tool for rational drug use management in medical institutions, and also provides a reference for relevant policy formulation.

KEYWORDS

Management Index System; Rational Drug Use; Key Monitoring Drugs

CITE THIS PAPER

Yangke He, Construction of Management Index System for Rational Drug Use of Key Monitoring Drugs. Social Security and Administration Management (2025) Vol. 6: 122-126. DOI: http://dx.doi.org/10.23977/socsam.2025.060116.

REFERENCES

[1] He W, Liu D, Yu A, & Zhao L. (2024). Policy Analysis of the Second Batch of Key Monitored Drugs for Rational Use in China. Herald of Medicine, 43(7), 1170–1176. 
[2] Bian Y, Chen M, Du S, Li W, Han L, & Yin Q, et al. (2023). Guidelines for Rational Use of the Second Batch of National Key Monitored Drugs. China Pharmacy, 34(20), 2433–2453. 
[3] Liu C, Zheng X, & Ge L. (2025). Current Status of Antibiotic Use Among Inpatients in a Cancer Hospital. Chinese Journal of Medicines and Clinical Practice, 25(1), 57–62. 
[4] Wang Q, Li W, & Xu X. (2024). Promoting Rational Drug Use Management in Stroke Centers under DRG Payment Reform. Pharmaceutical and Clinical Research, 32(4), 376–378. 
[5] Zhang S, Xu L, Wang P, Guo H, Huang Q, & Huang J. (2020). Preliminary Study on Strategies and Outcomes of Rational Drug Use Control in Hospitals. Chinese Journal of Hospital Administration, 36(S2), 51–52. 
[6] Wang Y, Li Y, Lü F, Liu Y, Wang S, & Qiu L, et al. (2020). Establishing and Implementing a Management System for Key Monitored Drugs. Chinese Journal of Medicines and Clinical Practice, 20(10), 1726–1729. 
[7] Guo Y, Shang X, Zhao C, & Zhang W. (2023). Effect of Pharmaceutical Care Interventions on Key Monitored Drugs in a Tertiary Hospital. Medical Journal of Chinese People's Armed Police Forces, 34(10), 857–860.

Downloads: 5859
Visits: 221862

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.